SCYNEXIS (SCYX) News Today → get a piece of the profit from this land (From True Market Insiders) (Ad) Free SCYX Stock Alerts $2.77 +0.36 (+14.94%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | americanbankingnews.comBrookline Capital Management Research Analysts Lift Earnings Estimates for SCYNEXIS, Inc. (NASDAQ:SCYX)May 12, 2024 | americanbankingnews.comBrookline Capital Management Analysts Raise Earnings Estimates for SCYNEXIS, Inc. (NASDAQ:SCYX)May 10, 2024 | markets.businessinsider.comBuy Recommendation: Scynexis’s Ibrexafungerp Promises Market Breakthrough and Financial GrowthMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal PipelineMay 10, 2024 | marketbeat.comSCYNEXIS, Inc. Forecasted to Earn FY2025 Earnings of $0.07 Per Share (NASDAQ:SCYX)SCYNEXIS, Inc. (NASDAQ:SCYX - Free Report) - Stock analysts at Brookline Capital Management lifted their FY2025 earnings estimates for SCYNEXIS in a research report issued on Wednesday, May 8th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings perMay 9, 2024 | investorplace.comSCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024May 8, 2024 | markets.businessinsider.comSCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 8, 2024 | finance.yahoo.comInvestors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five yearsApril 30, 2024 | finance.yahoo.comSCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)April 20, 2024 | finance.yahoo.comSCYNEXIS, Inc. (SCYX)April 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for SCYNEXIS on Strong Financials and Promising Pipeline ProspectsApril 9, 2024 | marketbeat.comSCYNEXIS, Inc. (NASDAQ:SCYX) Stake Trimmed by Stonepine Capital Management LLCStonepine Capital Management LLC lowered its position in SCYNEXIS, Inc. (NASDAQ:SCYX - Free Report) by 52.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,355,186 shares of the company's stock after selling 1,497,413 shares during tApril 9, 2024 | globenewswire.comSCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)April 4, 2024 | marketbeat.comFY2024 EPS Estimates for SCYNEXIS, Inc. Cut by Analyst (NASDAQ:SCYX)SCYNEXIS, Inc. (NASDAQ:SCYX - Free Report) - Equities researchers at Cantor Fitzgerald dropped their FY2024 EPS estimates for shares of SCYNEXIS in a note issued to investors on Monday, April 1st. Cantor Fitzgerald analyst L. Chen now forecasts that the company will earn ($0.46) per share for theMarch 29, 2024 | msn.comSCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023March 28, 2024 | stockhouse.comSCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comSCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 18, 2024 | marketbeat.comStockNews.com Lowers SCYNEXIS (NASDAQ:SCYX) to HoldStockNews.com cut shares of SCYNEXIS from a "buy" rating to a "hold" rating in a report on Monday.February 27, 2024 | marketbeat.comFederated Hermes Inc. Decreases Stake in SCYNEXIS, Inc. (NASDAQ:SCYX)Federated Hermes Inc. lowered its holdings in SCYNEXIS, Inc. (NASDAQ:SCYX - Free Report) by 7.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,804,700 shares of the company's stock after selling 369,214 shares during the period. FedeFebruary 21, 2024 | benzinga.comSCYNEXIS Stock (NASDAQ:SCYX) Insider TradesFebruary 13, 2024 | marketbeat.comSCYNEXIS, Inc. (NASDAQ:SCYX) Short Interest UpdateSCYNEXIS, Inc. (NASDAQ:SCYX - Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 1,150,000 shares, a decline of 18.4% from the January 15th total of 1,410,000 shares. Based on an average trading volume of 219,300 shares, the days-to-cover ratio is currently 5.2 days.February 10, 2024 | marketbeat.comSCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200 Day Moving Average of $2.27SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Below 200-Day Moving Average of $2.27February 2, 2024 | marketbeat.comSCYNEXIS (NASDAQ:SCYX) Stock Passes Below 200-Day Moving Average of $2.31SCYNEXIS (NASDAQ:SCYX) Share Price Passes Below Two Hundred Day Moving Average of $2.31February 1, 2024 | markets.businessinsider.comPromising Antifungal Drug Developments Bolster Buy Rating for SCYNEXISJanuary 30, 2024 | finance.yahoo.comSCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology ConferenceJanuary 30, 2024 | finance.yahoo.comSCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis ConferenceJanuary 8, 2024 | stockhouse.comDEADLINE TODAY: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmJanuary 6, 2024 | markets.businessinsider.comScynexis 48 Hour Deadline AlertJanuary 5, 2024 | finance.yahoo.comSCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, ItalyJanuary 1, 2024 | markets.businessinsider.comSCYX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYXDecember 29, 2023 | stockhouse.comINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmDecember 29, 2023 | barrons.comFINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with to Contact the FirmDecember 26, 2023 | stockhouse.comScynexis Deadline ReminderDecember 25, 2023 | markets.businessinsider.comTOP RANKED ROSEN LAW FIRM Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXDecember 23, 2023 | stockhouse.comSCYNEXIS, Inc. (SCYX) Securities Fraud: Contact Berger Montague To Discuss Your RightsDecember 22, 2023 | morningstar.comSCYNEXIS Inc SCYXDecember 21, 2023 | stockhouse.comDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmDecember 18, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of SCYNEXIS, Inc. (SCYX)December 17, 2023 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmDecember 17, 2023 | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXDecember 16, 2023 | barrons.comSCYX STOCK ALERT: Robbins LLP Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Against Scynexis, Inc.December 12, 2023 | stockhouse.comDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses to Contact the FirmDecember 11, 2023 | markets.businessinsider.comROSEN, LEADING TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXDecember 5, 2023 | stockhouse.comROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXDecember 4, 2023 | benzinga.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXDecember 3, 2023 | barrons.comSCYX Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc.Investors with Substantial Losses to Contact the Firm!December 3, 2023 | markets.businessinsider.comScynexis Ongoing Deadline AlertDecember 3, 2023 | barrons.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of In Excess of $100,000 to Contact the FirmNovember 30, 2023 | finance.yahoo.comShareholders in SCYNEXIS (NASDAQ:SCYX) are in the red if they invested five years agoNovember 28, 2023 | barrons.comScynexis Deadline Alert Get SCYNEXIS News Delivered to You Automatically Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter. Email Address get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land. Click here to see my #1 investment for 2024. SCYX Media Mentions By Week SCYX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCYX News Sentiment▼0.970.50▲Average Medical News Sentiment SCYX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCYX Articles This Week▼62▲SCYX Articles Average Week Get SCYNEXIS News Delivered to You Automatically Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LABP News ASMB News LTRN News DERM News YS News RLYB News VHAQ News IFRX News MNOV News MURA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCYX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SCYNEXIS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
